Breega — 2025 Investments
3 investments dated 2025 · listed companies and verified rows first · show all
Brink Therapeutics is a TechBio company developing programmable integrases, a nuclease-free platform for precise, large-payload genomic insertion of therapeutic genes for cell and gene therapy.
AI & Machine LearningBiotechDeep TechParis, FR
Jonathan Naccache(Co-founder (Directeur de la publication))in
Co-investorsKima VenturesKurma Partners
Alice & Bob develops quantum computing hardware based on the cat qubit, a qubit design with built-in error correction, and offers Helium, a testbed for error correction.
Deep TechHardwareQuantum Computing
Raphaël Lescanne(Founder)in
Co-investorsElaiaOpen Field CapitalSupernova InvestAtlantic Vantage PointC4 Ventures
Flow48 provides Revenue Based Financing and Invoice Financing to South African SMEs, letting businesses access working capital against future revenue or unpaid invoices without collateral or equity dilution.
FintechSaaS
Idriss Al Rifai(Founder)in
Co-investorsDaphniEvolution VenturesFirst Circle212468 CapitalBlockchain Founders Fund+4 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.